Emerging roles of ferroptosis in cardiovascular diseases

被引:0
|
作者
Kai Wang
Xin-Zhe Chen
Yun-Hong Wang
Xue-Li Cheng
Yan Zhao
Lu-Yu Zhou
Kun Wang
机构
[1] Qingdao University,Institute for Translational Medicine, The Affiliated Hospital of Qingdao University, College of Medicine
[2] Peking Union Medical College,State Key Laboratory of Cardiovascular Disease, Heart Failure center, Fuwai Hospital, National Center for Cardiovascular Diseases, Chinese Academy of Medical Sciences
[3] Shandong Provincial Maternal and Child Health Care Hospital affiliated to Qingdao University,Key Laboratory of Birth Regulation and Control Technology of National Health Commission of China
来源
关键词
D O I
暂无
中图分类号
学科分类号
摘要
The mechanism of cardiovascular diseases (CVDs) is complex and threatens human health. Cardiomyocyte death is an important participant in the pathophysiological basis of CVDs. Ferroptosis is a new type of iron-dependent programmed cell death caused by excessive accumulation of iron-dependent lipid peroxides and reactive oxygen species (ROS) and abnormal iron metabolism. Ferroptosis differs from other known cell death pathways, such as apoptosis, necrosis, necroptosis, autophagy and pyroptosis. Several compounds have been shown to induce or inhibit ferroptosis by regulating related key factors or signalling pathways. Recent studies have confirmed that ferroptosis is associated with the development of diverse CVDs and may be a potential therapeutic drug target for CVDs. In this review, we summarize the characteristics and related mechanisms of ferroptosis and focus on its role in CVDs, with the goal of inspiring novel treatment strategies.
引用
收藏
相关论文
共 50 条
  • [11] Emerging Roles of Inflammasomes in Cardiovascular Diseases
    Liao, Yingnan
    Liu, Kui
    Zhu, Liyuan
    FRONTIERS IN IMMUNOLOGY, 2022, 13
  • [12] Emerging Roles of Ceramide in Cardiovascular Diseases
    Shu, Hongyang
    Peng, Yizhong
    Hang, Weijian
    Li, Na
    Zhou, Ning
    Wang, Dao Wen
    AGING AND DISEASE, 2022, 13 (01): : 232 - 245
  • [13] Emerging roles of Sirtuin 2 in cardiovascular diseases
    Taneja, Arushi
    Ravi, Venkatraman
    Hong, Jun Young
    Lin, Hening
    Sundaresan, Nagalingam Ravi
    FASEB JOURNAL, 2021, 35 (10):
  • [14] The Emerging Role of Noncoding RNA Regulation of the Ferroptosis in Cardiovascular Diseases
    Zhang, Jing
    Liu, Xinran
    Li, Xiaozhong
    Cai, Yuxi
    Zhou, Yiwen
    Wang, Qiong
    Xu, Zhou
    Xia, Panpan
    Yang, Pingping
    Jun, Lei
    Yu, Peng
    Shi, Ao
    OXIDATIVE MEDICINE AND CELLULAR LONGEVITY, 2022, 2022
  • [15] Emerging roles of absent in melanoma 2 in cardiovascular diseases
    Zhao, Zhan-Zhi
    Zheng, Xi-Long
    Jiang, Zhi-Sheng
    CLINICA CHIMICA ACTA, 2020, 511 : 14 - 23
  • [16] Emerging roles of sphingosylphosphorylcholine in modulating cardiovascular functions and diseases
    Di Ge
    Hong-wei Yue
    Hong-hong Liu
    Jing Zhao
    Acta Pharmacologica Sinica, 2018, 39 : 1830 - 1836
  • [17] Emerging roles of sphingosylphosphorylcholine in modulating cardiovascular functions and diseases
    Ge, Di
    Yue, Hong-wei
    Liu, Hong-hong
    Zhao, Jing
    ACTA PHARMACOLOGICA SINICA, 2018, 39 (12) : 1830 - 1836
  • [18] Emerging roles of ferroptosis in glioma
    Shi, Jiaqi
    Yang, Ning
    Han, Mingzhi
    Qiu, Chen
    FRONTIERS IN ONCOLOGY, 2022, 12
  • [19] The emerging roles of long noncoding RNAs in common cardiovascular diseases
    Jiang, Xiaoying
    Ning, Qilan
    HYPERTENSION RESEARCH, 2015, 38 (06) : 375 - 379
  • [20] Emerging roles of HOTAIR lncRNA in the pathogenesis and prognosis of cardiovascular diseases
    Haybar, Habib
    Hadi, Hakimeh
    Purrahman, Daryush
    Mahmoudian-Sani, Mohammad Reza
    Saki, Najmaldin
    BIOMARKERS IN MEDICINE, 2024, 18 (05) : 203 - 219